When is ring vaccination appropriate, and what considerations apply?

• A. When a vaccine is universally available to everyone.
• B. When transmission is focal and vaccine supplies allow targeted vaccination; consider population acceptance, cold chain, and timing relative to exposure.
• C. Only after clinical treatment of cases.
• D. When there is no risk of transmission.

Answer: (B)

Ring vaccination targets the people most at risk by vaccinating the contacts around a confirmed case to create a protective barrier that stops further spread. It’s best when transmission is focal rather than widespread and when vaccine supplies are limited enough that Pareto-focused vaccination around cases will have the biggest impact. A rapid response is essential: cases must be detected quickly, and contacts traced and vaccinated promptly to prevent those contacts from developing or transmitting disease.

Key considerations include whether the community will participate (population acceptance), whether the vaccine can be stored and transported safely (cold chain), and whether vaccination can occur within the window after exposure to be protective. If vaccination happens too late or if contact tracing isn’t effective, the strategy loses its value. Ring vaccination differs from universal vaccination and is most suitable when you’re working to halt transmission around identified cases with finite vaccine resources.